UBT251, a novel triple GLP-1, GIP, and glucagon receptor agonist, in adults with overweight or obesity: A multicenter, randomized phase 2 trial

Cell Metabolism · Elsevier

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles